Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001635088-26-000123

President & Immunovant CEO sold 200,000 shares at $36.31 ($7,262,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Venker Eric President & Immunovant CEO 2026-11-03 Sale 10b5-1 −200,000 $36.31 $7,262,000 999,154 D: show line 1 in the form
Open-market sales · 200,000 sh · avg $36.31 · $7,262,000
Loading xslF345X06/wk-form4_1793920284.xml…